| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3824533 | Progrès en Urologie | 2008 | 9 Pages |
Abstract
This study shows that pT3 tumours treated with therapeutic associations including RRP presents an excellent specific survival at 10 years. The determination of biochemical recurrence prognostic factors could help to select patients who need complementary treatments after surgery.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
J.-B. Roche, B. Malavaud, M. Soulié, M. Cournot, X. Gamé, C. Mazerolles, J.-M. Bachaud, P. Plante, P. Rischmann,